跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,475 条关于
“OBI-221”
全部
5,475
临床试验
2,746
药物
2,229
机构
28
资讯
472
8个月前
OBI Pharma and TegMine Therapeutics Form Global License Partnership for Novel Glycan-Targeting ADC
去年
OBI Pharma Initiates Phase 1/2 Trial for Novel TROP2-Targeted ADC OBI-902 in Advanced Solid Tumors
去年
OBI Pharma's Novel TROP2 ADC OBI-902 Receives FDA IND Clearance for Phase 1/2 Trial Using Proprietary GlycOBI® Technology
去年
EuMentis Therapeutics Receives FDA Clearance for Phase 2 Trial of Novel PDE10A Inhibitor EM-221 in Schizophrenia
去年
Error parsing response
2年前
PetVivo and Orthobiologic Innovations Partner to Advance Osteoarthritis Treatment for Pets
9个月前
Arcus and Gilead Discontinue TIGIT Therapy After Phase III Gastric Cancer Trial Failure
2年前
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis
去年
Urticaria Clinical Trial Pipeline Heats Up with Novel Therapies in Development
去年
Amaran Biotech Partners with Nippon Fine Chemical to Advance Nanoparticle-Based Drug Manufacturing
第 1 页,共 48 页
上一页
下一页